222 related articles for article (PubMed ID: 24005194)
21. Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion.
Owens K; Glassman SD; Howard JM; Djurasovic M; Witten JL; Carreon LY
Eur Spine J; 2011 Apr; 20(4):612-7. PubMed ID: 20582554
[TBL] [Abstract][Full Text] [Related]
22. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
23. Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.
Cole T; Veeravagu A; Jiang B; Ratliff JK
J Bone Joint Surg Am; 2014 Sep; 96(17):1409-16. PubMed ID: 25187578
[TBL] [Abstract][Full Text] [Related]
24. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
[No Abstract] [Full Text] [Related]
25. MOS short form 36 and Oswestry Disability Index outcomes in lumbar fusion: a multicenter experience.
Glassman S; Gornet MF; Branch C; Polly D; Peloza J; Schwender JD; Carreon L
Spine J; 2006; 6(1):21-6. PubMed ID: 16413443
[TBL] [Abstract][Full Text] [Related]
26. Obesity and spine surgery: relation to perioperative complications.
Patel N; Bagan B; Vadera S; Maltenfort MG; Deutsch H; Vaccaro AR; Harrop J; Sharan A; Ratliff JK
J Neurosurg Spine; 2007 Apr; 6(4):291-7. PubMed ID: 17436915
[TBL] [Abstract][Full Text] [Related]
27. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
Carragee EJ; Chu G; Rohatgi R; Hurwitz EL; Weiner BK; Yoon ST; Comer G; Kopjar B
J Bone Joint Surg Am; 2013 Sep; 95(17):1537-45. PubMed ID: 24005193
[TBL] [Abstract][Full Text] [Related]
29. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
30. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.
Comer GC; Smith MW; Hurwitz EL; Mitsunaga KA; Kessler R; Carragee EJ
Spine J; 2012 Oct; 12(10):881-90. PubMed ID: 23098617
[TBL] [Abstract][Full Text] [Related]
31. rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial.
Hurlbert RJ; Alexander D; Bailey S; Mahood J; Abraham E; McBroom R; Jodoin A; Fisher C
Spine (Phila Pa 1976); 2013 Dec; 38(25):2139-48. PubMed ID: 24296479
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
33. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
[TBL] [Abstract][Full Text] [Related]
34. Early complications related to approach in thoracic and lumbar spine surgery: a single center prospective study.
Campbell PG; Malone J; Yadla S; Maltenfort MG; Harrop JS; Sharan AD; Ratliff JK
World Neurosurg; 2010 Apr; 73(4):395-401. PubMed ID: 20849799
[TBL] [Abstract][Full Text] [Related]
35. Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
[TBL] [Abstract][Full Text] [Related]
36. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients.
Lu DC; Tumialán LM; Chou D
J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of L5-S1 axial lumbar interbody fusion (AxiaLIF): a comparison with and without the use of recombinant human bone morphogenetic protein-2.
Gerszten PC; Tobler WD; Nasca RJ
Spine J; 2011 Nov; 11(11):1027-32. PubMed ID: 22122835
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly.
Hoffmann MF; Jones CB; Sietsema DL
J Orthop Surg Res; 2013 Jan; 8():1. PubMed ID: 23317417
[TBL] [Abstract][Full Text] [Related]
40. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons.
Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U
J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
